Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Basic tumor immunology

Short report

Circulating CD14^high CD16^low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

Online download statistics by month:

Online download statistics by month: June 2020 to December 2022

	Abstract	Full	Pdf
Jun 2020	229	230	112
Jul 2020	72	72	30
Aug 2020	54	54	12
Sep 2020	74	74	37
Oct 2020	53	53	17
Nov 2020	61	61	26
Dec 2020	87	87	30
Jan 2021	98	98	27
Feb 2021	64	65	17
Mar 2021	105	105	37
Apr 2021	89	89	25
May 2021	61	61	21
Jun 2021	66	66	47
Jul 2021	82	82	20
Aug 2021	66	66	18
Sep 2021	49	49	16
Oct 2021	65	65	33
Nov 2021	77	77	38
Dec 2021	54	55	16
Jan 2022	55	60	22
Feb 2022	30	37	14
Mar 2022	49	52	21
Apr 2022	52	60	19
May 2022	76	78	31
Jun 2022	70	81	25
Jul 2022	48	49	12
Aug 2022	47	52	28
Sep 2022	65	69	33
Oct 2022	73	73	14
Nov 2022	63	70	26
Dec 2022	50	51	15
Total	2184	2241	839